Biotechnology & Medical Research
Galapagos NV : 2016 revenues increased by 91.0 million euros ($96.41 million) to 151.6 million euros . 2016 operating loss reduced by 77.9 million euros to 11.5 euros million . 2016 net profit of 54.0 million euros, compared to a net loss of 118.4 million euros in 2015 . 2016 cash balance increased...
Shanghai RAAS Blood Products Co Ltd :Says preliminary 2016 net profit up 11.8 percent y/y at 1.6 billion yuan ($232.85 million).
Oxford Biomedica Plc : Cyclophosphamide and Trovax independently shown to induce highly beneficial anti-tumour immune responses .Both drugs resulting in significantly prolonged survival of advanced colorectal cancer patients.
Pledpharma AB (publ) :Q4 net loss 11.5 million Swedish crowns ($1.3 million) versus loss 8.8 million crowns year ago.
No related earnings announcements are currently scheduled within the next 7 days.